go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Vermont rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $4,677 · 10th–90th $4,677$4,6770%50%100%$4,677Professionalmedian $3,548 · 10th–90th $3,548$6,0260%50%90th$3,548$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$6,025.60
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Facility
Modifier
Global
Typical Low
$4,677.35
Median
$4,677.35
Typical High
$4,677.35
United
Setting
Professional
Modifier
Global
Typical Low
$3,162.28
Median
$4,168.69
Typical High
$10,715.19